Differentiation of prostatic carcinoma and benign prostatic hyperplasia: Correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology

Journal of Magnetic Resonance Imaging

Volumn 9, Issue 2, 1999, Pages 311-316

  Turnbull, Lindsay W ^a   Buckley, David L ^a   Turnbull, Lesley S ^b   Liney, Gary P ^a   Knowles, Adrian J ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Dynamic MR imaging; Histopathology; Prostate

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY;

AGED; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0033045350     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199902)9:2<311::AID-JMRI24>3.0.CO;2-W     Document Type: Article

References (14)

1. Schnall MD, Imai Y, Tomaszewski J, Pollack HM, Lenkinski RE, Kressel HY. Prostate cancer: local staging with endorectal surface coil MRI. Radiology 1991;178:797-802.
2. Jager GJ, Barentsz JO, de la Rosette JJMCH, Rosenbusch G. Preliminary results of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. Radiologe 1994;34:129-133.
3. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM. Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 1993;150:391-395.
4. Lencioni R, Menchi D, Caramella D, Di Giulio M, Carini M, Bartolozzi C. Determining the volume of prostate carcinoma: value of MRI with an endorectal surface coil. In: Abstracts of the 12th Congress of the SMR, 1995. p1501.
5. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989;170:681-686.
6. Kahn T, Burrig K, Scmitz-Drager B, et al. Prostatic carcinoma and benign prostatic hypertrophy: MR imaging with histopathologic correlation. Radiology 1989;173:847-851.
7. Nishimura K, Hida S, Nishio Y, Yoshida O, Nakano Y. Clinical application of MRI for urological malignancy. 3: A new trial of MRI for bladder cancer and prostatic cancer; surface coil and Gd-DTPA. Acta Urol Jpn 1988;34:2097-3100.
8. Buckley DL, Kerslake RW, Blackband SJ, Horsman A. Quantitative analysis of multislice Gd-DTPA enhanced dynamic MR-images using an automated simplex minimization procedure. Magn Reson Med 1994;32:646-651.
9. Schiebler M, Tomaszewski J, Bezzi M, et al. Prostatic carcinoma and benign prostatic hypertrophy: correlation of high resolution MR and histopathologic findings. Radiology 1989;172:131-137.
10. Brem RF, Tempany CM, Yang A, et al. Magnetic resonance imaging in the detection of occult prostatic cancer. J Urol 1990;143:195, abstract 26.
11. Huch Böni RA, Boner JA, Lütolf UM, Trinkler F, Pestalozzi DM, Krestin GP. Contrast-enhanced endorectal coil MRI in local staging of prostatic carcinoma. J Comput Assist Tomogr 1995;19:232-237.
12. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357-367.
13. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Phys Chem Phys Med NMR 1984;16:167-172.
14. Hittmair K, Gomiscek G, Langenberger M, Recht K, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567-571.